Renaissance Technologies LLC Invests $621,000 in Atomera Incorporated $ATOM

Renaissance Technologies LLC purchased a new position in shares of Atomera Incorporated (NASDAQ:ATOMFree Report) in the 1st quarter, HoldingsChannel.com reports. The fund purchased 163,066 shares of the technology company’s stock, valued at approximately $621,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. HRT Financial LP acquired a new stake in Atomera in the 4th quarter worth about $29,000. AQR Capital Management LLC increased its stake in Atomera by 25.2% during the 4th quarter. AQR Capital Management LLC now owns 22,210 shares of the technology company’s stock worth $49,000 after buying an additional 4,475 shares in the last quarter. Abel Hall LLC acquired a new position in shares of Atomera during the first quarter valued at approximately $53,000. The Manufacturers Life Insurance Company acquired a new position in shares of Atomera during the second quarter valued at approximately $53,000. Finally, Alliancebernstein L.P. purchased a new position in shares of Atomera in the third quarter valued at approximately $61,000. 30.79% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Atomera

In other news, CFO Francis Laurencio sold 20,400 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $9.44, for a total transaction of $192,576.00. Following the transaction, the chief financial officer directly owned 253,353 shares in the company, valued at $2,391,652.32. The trade was a 7.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 8.10% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

ATOM has been the topic of a number of research analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Atomera in a research note on Wednesday. Wall Street Zen downgraded Atomera from a “hold” rating to a “sell” rating in a research note on Monday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

Check Out Our Latest Report on Atomera

Atomera Stock Performance

ATOM opened at $5.60 on Monday. The firm has a market capitalization of $218.51 million, a PE ratio of -8.62 and a beta of 2.11. Atomera Incorporated has a twelve month low of $1.89 and a twelve month high of $12.36. The firm’s 50-day moving average price is $6.71 and its 200 day moving average price is $6.18.

Atomera (NASDAQ:ATOMGet Free Report) last announced its quarterly earnings data on Tuesday, August 4th. The technology company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by ($0.04). The business had revenue of $0.16 million for the quarter, compared to analysts’ expectations of $0.10 million. Atomera had a negative net margin of 9,742.17% and a negative return on equity of 77.91%.

Atomera Profile

(Free Report)

Atomera Inc is a materials engineering company that develops and licenses advanced thin film technologies for the semiconductor industry. Its flagship offering, Mears Silicon Technology (MST), is designed to enhance transistor performance, improve power efficiency and boost device yields. Atomera’s solutions are integrated into existing fabrication processes without major changes to equipment or materials flows, enabling foundries and integrated device manufacturers to adopt the technology with minimal disruption.

At the core of Atomera’s business model is the licensing and patent-licensing of MST.

Featured Stories

Want to see what other hedge funds are holding ATOM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atomera Incorporated (NASDAQ:ATOMFree Report).

Institutional Ownership by Quarter for Atomera (NASDAQ:ATOM)

Receive News & Ratings for Atomera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atomera and related companies with MarketBeat.com's FREE daily email newsletter.